泰格医药 (300347.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(泰格医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,709,371,136.501,698,039,901.951,660,204,321.441,733,561,522.871,939,627,566.421,906,278,996.311,804,571,375.28
 营业收入(元) 1,709,371,136.501,698,039,901.951,660,204,321.441,733,561,522.871,939,627,566.421,906,278,996.311,804,571,375.28
二、营业总成本(元) 1,400,280,672.741,320,982,041.951,305,287,804.371,411,938,158.401,422,161,050.211,359,734,127.691,360,291,377.24
 营业成本(元) 1,072,136,789.53993,115,963.551,032,080,670.151,164,590,500.121,141,156,680.451,140,714,552.131,089,048,900.22
 研发费用(元) 47,404,537.4360,788,070.3363,906,152.5266,211,979.7867,260,692.7163,563,095.8564,519,361.97
 营业税金及附加(元) 7,891,731.826,793,343.327,700,539.006,430,704.116,631,156.867,955,337.066,849,492.11
 销售费用(元) 43,557,432.8954,925,580.8746,452,309.6354,611,219.0243,705,245.6244,087,288.7844,911,069.53
 管理费用(元) 181,810,372.26199,547,455.36177,068,490.82122,658,296.31181,072,116.52175,547,373.47170,923,614.77
 财务费用(元) 47,479,808.815,811,628.52-21,920,357.75-2,564,540.94-17,664,841.95-72,133,519.60-15,961,061.36
 资产减值损失(元) -2,232,770.28-672,199.45-7,752,329.78-17,960,837.46-3,545,964.39-2,726,600.21-5,491,837.06
 信用减值损失(元) -16,780,054.85-17,006,965.40-10,652,196.93-4,793,217.60-12,020,720.99-6,321,414.15-15,237,624.14
三、其他经营收益
 加:公允价值变动收益(元) 63,991,193.91-111,156,413.8412,753,272.78-357,623,678.46180,636,717.32353,344,866.79176,412,728.63
 加:投资收益(元) 38,414,714.8074,334,607.76-3,591,151.18210,439,874.2328,833,315.9673,117,434.6425,784,682.29
 资产处置收益(元) 1,185,208.54337,352.041,152,370.67-233,308.3051,116.44-2,360.66-3,540.15
 其他收益(元) 4,257,724.791,978,950.7015,369,745.7823,764,087.921,705,503.853,743,210.295,153,375.29
四、营业利润(元) 397,926,480.67324,873,191.81362,196,228.41175,216,284.80713,126,484.40967,700,005.32630,897,782.90
 加:营业外收入(元) 386,786.514,649,174.62301,243.156,582,883.732,321,344.583,701,710.59848,031.87
 减:营业外支出(元) 1,341,468.401,793,397.41133,267.617,735,525.42123,506.933,318,750.94683,686.74
五、利润总额(元) 396,971,798.78327,728,969.02362,364,203.95174,063,643.11715,324,322.05968,082,964.97631,062,128.03
 减:所得税费用(元) 51,415,015.7482,720,648.4949,793,830.5651,983,771.2895,567,343.05128,318,632.5062,736,467.76
六、净利润(元) 345,556,783.04245,008,320.53312,570,373.39122,079,871.83619,756,979.00839,764,332.47568,325,660.27
(一)按经营持续性分类
  持续经营净利润(元) 345,556,783.04245,008,320.53312,570,373.39122,079,871.83619,756,979.00839,764,332.47568,325,660.27
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 320,580,064.49257,776,848.27235,072,002.70145,245,558.95491,267,423.96819,881,913.33568,455,092.87
  少数股东损益(元) 24,976,718.55-12,768,527.7477,498,370.69-23,165,687.12128,489,555.0419,882,419.14-129,432.60
 扣除非经常性损益后的净利润(元) 251,772,880.13337,272,930.18303,052,196.14278,817,263.23404,950,398.38412,256,637.78381,217,753.93
七、每股收益
 一、基本每股收益(元) 0.370.300.270.170.560.950.66
 二、稀释每股收益(元) 0.370.300.270.170.560.950.66
八、其他综合收益(元) -20,338,949.11-8,131,721.34-22,239,213.91-13,454,670.19-36,192,368.36149,716,989.32-46,553,885.08
 归属于母公司股东的其他综合收益(元) -13,837,143.26-4,750,229.72-7,569,853.71-3,455,046.98-28,432,302.12100,730,983.90-30,860,474.07
 归属于少数股东的其他综合收益(元) -6,501,805.85-3,381,491.62-14,669,360.20-9,999,623.21-7,760,066.2448,986,005.42-15,693,411.01
九、综合收益总额(元) 325,217,833.93236,876,599.19290,331,159.48108,625,201.64583,564,610.64989,481,321.79521,771,775.19
 归属于母公司所有者的综合收益总额(元) 306,742,921.23253,026,618.55227,502,148.99141,790,511.97462,835,121.84920,612,897.23537,594,618.80
 归属于少数股东的综合收益总额(元) 18,474,912.70-16,150,019.3662,829,010.49-33,165,310.33120,729,488.8068,868,424.56-15,822,843.61
公告日期 2024-10-302024-08-292024-04-262024-03-292023-10-282023-08-262023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院